Veteran BPO executives Mark Lyndsell and Troy Sanders join TOG as the company expands its global delivery capabilities and advances its Experience Process Outsourcing strategy

ST. PETERSBURG, Fla., Sept. 17, 2026 (GLOBE NEWSWIRE) — The Office Gurus (TOG), a business segment of Superior Group of Companies, Inc. (NASDAQ: SGC), announced the appointments of Mark Lyndsell as Executive Vice President of Global Operations and Troy Sanders as Vice President of Business Development. Together, they bring more than six decades of BPO, contact center, operations and sales leadership experience to TOG.

“TOG has reached an important point in our evolution,” said Dominic Leide, President of The Office Gurus. “Mark and Troy bring the experience and leadership to help us significantly scale the successful, technology-driven platform we’ve built.”

Lyndsell brings more than 30 years of global operations experience, most recently as Senior Vice President, Delivery, Americas at TTEC, leading a multi-country delivery organization generating approximately $850 million in annual revenue. As EVP of Global Operations, he will lead TOG’s global operations, focusing on operational excellence and advancing the company’s Experience Process Outsourcing (EPO) delivery model.

Sanders brings more than 30 years of BPO and contact center sales leadership experience, including new business development for organizations such as iQor and Startek. As VP of Business Development, he will focus on expanding TOG’s new-client pipeline and brings the relationship-based sales mentality that TOG values.

The appointments support TOG’s continued advancement of its EPO strategy and its investment in GuruSuite iX, its AI-enabled technology ecosystem supporting agent performance, quality assurance, training and customer interaction automation. “Our objective isn’t simply to become bigger — it’s to become a better, more capable partner for our clients,” Leide said.

Disclosure Regarding Forward-Looking Statements

Certain matters discussed in this press release are “forward-looking statements” intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements can generally be identified by use of the words “may,” “will,” “should,” “could,” “expect,”“anticipate,” “estimate,” “believe,” “intend,” “project,” “potential,” or “plan” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements in this press release include statements regarding the Company’s capital allocation strategy and growth. Such forward-looking statements are subject to certain risks and uncertainties that may materially adversely affect the anticipated results. Such risks and uncertainties include, but are not limited to, the factors described in the Company’s filings with the Securities and Exchange Commission (“SEC”), including those risks described in Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 entitled “Risk Factors” and the Quarterly Report on Form 10-Q for the quarter ended June 30, 2026. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements made herein and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are only made as of the date of this press release and we disclaim any obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances, except as may be required by law.

About The Office Gurus

The Office Gurus is a global provider of customer experience and business process outsourcing solutions, combining engaged people, operational expertise and AI-enabled technology to help organizations improve customer experience and business performance.

About Superior Group of Companies, Inc. (SGC)

Established in 1920, Superior Group of Companies is comprised of three attractive business segments each serving large, fragmented and growing addressable markets. Across Healthcare Apparel, Branded Products and Contact Centers, each segment enables businesses to create extraordinary brand engagement experiences for their customers and employees. SGC’s commitment to service, quality, advanced technology, and omnichannel commerce provides unparalleled competitive advantages. We are committed to enhancing shareholder value by continuing to pursue a combination of organic growth and strategic acquisitions. For more information, visit www.superiorgroupofcompanies.com.

Contact:
Investor Relations
Investors@superiorgroupofcompanies.com

Updated guidelines establish a dedicated framework for routine MRD assessment across the multiple myeloma patient journey

clonoSEQ named as an FDA-cleared assay for MRD assessment, with 10-6 sensitivity now preferred

SEATTLE, Sept. 17, 2026 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today highlighted significant updates to the National Comprehensive Cancer Network® Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Multiple Myeloma that further establish highly sensitive minimal (or measurable) residual disease (MRD) assessment as an important tool in myeloma care.

For the first time, NCCN Guidelines® include a dedicated page that outlines Principles of MRD Testing, underscoring the importance of MRD testing in modern myeloma management. The new page, MYEL-E, gives clinicians a clearer, more consistent approach to using MRD testing in patients. The update builds on years of clinical evidence demonstrating that MRD negativity is associated with longer progression-free survival and overall survival. By bringing MRD testing recommendations together in one place, the updated guidelines may help support more informed conversations between patients and their care teams about disease status, treatment decisions, and ongoing monitoring.

Significant additions to the NCCN MRD recommendations include:

  • Bone marrow-based MRD assessment is recommended using next-generation sequencing (NGS) with an FDA-approved assay such as clonoSEQ® or multicolor flow cytometry. Notably, clonoSEQ is the only assay specifically named in the NCCN Guidelines.
  • 10-6 is stated as the preferred sensitivity for MRD testing due to its higher prognostic value, with 10-5 described as the minimum recommended sensitivity.
  • Recommended timepoints for MRD assessment have been expanded to include annual testing during maintenance, and after later lines of therapy including after CAR T-cell therapy, reinforcing the role of MRD as a longitudinal measure of disease status.

Most importantly, the updated guidelines reflect the growing clinical utility of MRD assessment in helping clinicians evaluate response to therapy and personalize treatment decisions. The guidelines note that MRD negativity and sustained MRD negativity can help guide treatment escalation, de-escalation, and maintenance therapy as part of a shared decision-making process with patients. Conversely, rising MRD positivity may prompt, at a minimum, closer monitoring and clinical evaluation.

“The updated NCCN Guidelines represent an important step forward in how we use MRD in multiple myeloma. Greater sensitivity matters, as it is associated with clinical outcomes, and assessing MRD at a sensitivity of 10⁻⁶ gives us a more precise understanding of the depth of response,” said Ola Landgren, MD, PhD, director of the Sylvester Myeloma Institute at Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine. “Equally important is the recognition that MRD should be followed over time. Sustained MRD negativity is more informative than a single negative result. Incorporating MRD into decisions about treatment duration, including the possibility of discontinuing therapy in selected patients with sustained MRD negativity, moves the field toward a more individualized approach in which we aim not only to achieve deep responses, but also to avoid unnecessary treatment.”

“NCCN Guidelines play an important role in advancing the standard of care for patients, particularly by helping community oncologists access and apply the latest guidance,” said Susan Bobulsky, Chief Commercial Officer, MRD, Adaptive Biotechnologies. “The updated myeloma guidelines provide more detailed recommendations for MRD testing timepoints and frequency, helping clinicians incorporate MRD assessment into care throughout the myeloma treatment continuum. These updates underscore clonoSEQ’s established leadership in hematology MRD testing and reflect the continued evolution of the field toward MRD-informed patient care.”

The latest NCCN Guidelines can be accessed here.

About clonoSEQ
clonoSEQ® is the first and only FDA-cleared in vitro diagnostic (IVD) test for detecting and tracking minimal (or measurable) residual disease (MRD) in patients with multiple myeloma (MM) or B-cell acute lymphoblastic leukemia (B-ALL) using bone marrow, and in patients with chronic lymphocytic leukemia (CLL) using blood or bone marrow. clonoSEQ is also available in diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and other lymphoid cancers and specimen types as a CLIA-validated laboratory-developed test (LDT). clonoSEQ is covered by Medicare for MM, CLL, ALL, DLBCL and MCL.

clonoSEQ identifies and quantifies DNA sequences in malignant cells—detecting one cancer cell in one million healthy cells—to help clinicians and researchers assess and monitor MRD with precision over time. It delivers standardized, sensitive results that inform treatment decisions, predict outcomes, and detect relapses earlier. clonoSEQ has been extensively studied in more than 300 peer-reviewed publications.

clonoSEQ is CE-marked under the EU In Vitro Diagnostic Regulation (IVDR). For intended use details in the EU, see the instructions for use, available on request.

To review the FDA-cleared uses of clonoSEQ, visit clonoSEQ.com/technical-summary.

About Adaptive Biotechnologies
Adaptive Biotechnologies (“we” or “our”) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature’s most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision, and speed. We apply our platform to partner with biopharmaceutical companies, inform drug development, and develop clinical diagnostics across our two business areas: Minimal Residual Disease (MRD) and Immune Medicine. Our commercial products and clinical pipeline enable the diagnosis, monitoring, and treatment of diseases such as cancer, autoimmune disorders, and infectious diseases. Our goal is to develop and commercialize immune-driven clinical products tailored to each individual patient.

Forward-Looking Statements
This press release contains forward-looking statements that are based on management’s beliefs and assumptions and on information currently available to management. All statements contained in this release other than statements of historical fact are forward-looking statements, including statements regarding our ability to develop, commercialize and achieve market acceptance of our current and planned products and services, our research and development efforts, and other matters regarding our business strategies, use of capital, results of operations and financial position, and plans and objectives for future operations.

In some cases, you can identify forward-looking statements by the words “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. These risks, uncertainties and other factors are described under “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in the documents we file with the Securities and Exchange Commission from time to time. We caution you that forward-looking statements are based on a combination of facts and factors currently known by us and our projections regarding the future, about which we cannot be certain. As a result, the forward-looking statements may not prove to be accurate. The forward-looking statements in this press release represent our views as of the date hereof. We undertake no obligation to update any forward-looking statements for any reason, except as required by law.

Note: NCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.

ADAPTIVE INVESTORS
Karina Calzadilla, Vice President, Investor Relations and FP&A
201-396-1687
investors@adaptivebiotech.com

ADAPTIVE MEDIA
Erica Jones, Associate Corporate Communications Director
206-279-2423
media@adaptivebiotech.com

This order, placed by Alta Ares, marks:

  • A first commercial order for more than 100 battery packs intended for the interceptor drone developed by Alta Ares, a French company selected by the DGA as part of the ELISA innovation partnership
  • The culmination of nearly six months of co-development between the Novacium and Alta Ares teams, validated by a successful test campaign involving ten prototypes in July 2026;
  • An AA NOVA 6S3P 15,000 mAh pack that is lighter than Alta Ares’ reference battery, thanks to an optimized design and the higher energy density of Novacium’s silicon-based cells.

MONTREAL and SOLAIZE, France, Sept. 17, 2026 (GLOBE NEWSWIRE) — HPQ Silicon Inc. (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08) is pleased to inform its shareholders that its strategic partner, NOVACIUM SAS, a French deep-tech company specializing in the development and production of silicon-based anode materials for lithium-ion batteries, has announced that it has received from Alta Ares a first commercial order for the supply of more than 100 AA NOVA 6S3P 15,000 mAh battery packs incorporating lithium-ion cells using its silicon-based anode technology.

These packs are intended to power the X-Lock, Alta Ares’ interceptor drone. The X-Lock is a short- to medium-range quadcopter interceptor guided by the company’s onboard artificial intelligence software, Pixel Lock. This order represents the first commercial application of Novacium’s silicon-based anode technology in an interceptor drone system, a European counter-drone defence solution developed in collaboration with major industrial players [1].

Alta Ares is a French defence technology company specializing in counter-drone systems and onboard artificial intelligence. Selected alongside MBDA as part of the ELISA (Équipement Léger d’Interception de Système Autonome) innovation partnership launched by France’s Directorate General of Armaments (DGA), the company also won a NATO innovation challenge in 2025 focused on the early detection and identification of aerial threats. It subsequently participated, alongside other companies, in an integrated systems test campaign conducted at DGA sites in collaboration with NATO and Ukrainian representatives [1][2]. Its Pixel Lock software and technologies are used and have been proven in real combat conditions in Ukraine [3].

Novacium is approaching this project with a growing presence in the French and European defence ecosystem. In July 2026, the company received from LN Innov, Novacium’s partner in the electric propulsion system (“EPS”), a first order for the supply of GEN3 6S1P 6,000 mAh battery packs for FPV (First Person View) drones intended for a regiment of the French Army.

Novacium has also entered into discussions with the Directorate General of Armaments (DGA) regarding a potential project that could be submitted under the RAPID program (Régime d’appui à l’innovation duale)  administered by the Defence Innovation Agency (AID). No funding decision has been made at this stage. The company has also held discussions with the NATO Energy Security Centre of Excellence, based in Vilnius, regarding energy autonomy issues for armed forces.

These initiatives and collaborations illustrate Novacium’s progress in evaluating its technologies for defence applications related to energy storage and energy autonomy.

Nearly Six Months of Collaboration Between Novacium and Alta Ares

This order is the culmination of co-development work carried out in close collaboration by the Novacium and Alta Ares teams for nearly six months. The objective was to design a battery pack that precisely meets the demanding specifications of an interceptor drone in terms of power, reliability and onboard weight.

Pack Batteries - Batteries Pack AA NOVA 6S3P
Image 1) The AA NOVA 6S3P 15,000 mAh battery pack developed by Novacium with Alta Ares

In July 2026, a test campaign was conducted on ten AA NOVA pack prototypes. These prototypes fully met the performance and reliability criteria established by Alta Ares, leading to this first commercial order for more than 100 units. The ordered packs will be delivered to Alta Ares before the end of September 2026. This first order could subsequently lead to an ongoing supply agreement, subject to in-service results and Alta Ares’ procurement decisions.

A Battery Designed for Performance and Weight Reduction

The AA NOVA 6S3P 15,000 mAh pack incorporates 18 cylindrical 21700 GEN3 “high-current” cells rated at 5,000 mAh each. These cells are capable of a 25C discharge rate, equivalent to a maximum current of 125 A per cell, providing a particularly high level of power that is essential during the acceleration and manoeuvring phases of an interceptor drone.

Beyond power, weight reduction was the differentiating factor during testing. At performance levels that were at least equivalent, the AA NOVA pack proved lighter than the reference battery previously used by Alta Ares. This weight advantage results from an optimized pack design and the higher energy density of Novacium’s silicon-based cells compared with conventional graphite-anode cells.

For an interceptor drone, reducing weight can, depending on the aircraft configuration and operating conditions, help improve parameters such as agility, acceleration, endurance or available payload. These parameters are particularly important in an interception mission, where speed and responsiveness play an essential role.

In parallel with this first order, the Novacium and Alta Ares teams are continuing their work to further improve battery performance. The packs in this first batch incorporate 5,000 mAh GEN3 “high-current” cells. Future versions could incorporate 6,000 mAh GEN4 “high-current” cells currently under development, with the objective of increasing pack capacity and, depending on the selected configuration, endurance or available payload, while maintaining the required power level.

“Designing the battery for the interceptor drone of a company selected under a DGA program and which won a NATO innovation challenge is an important milestone for the entire team,” said Jed Kraiem, co-founder and Chief Operating Officer of Novacium SAS. “This order is the culmination of nearly six months of work carried out in close collaboration with the Alta Ares teams. It demonstrates that our silicon-based anode technology provides a concrete and measurable advantage [4], in this case significant weight reduction at performance levels that are at least equivalent, in one of the most demanding defence applications. This first order helps position Novacium as a credible French player in the development of advanced energy solutions for drone systems, an area that represents a major technological and industrial sovereignty challenge. Additional discussions are already underway to extend this collaboration.”

“For an interceptor like the X-Lock, every gram counts: the battery directly affects the aircraft’s agility and endurance. The packs developed with Novacium enabled us to reduce weight while maintaining at least equivalent performance, which translates very concretely in flight. We appreciated the responsiveness and professionalism of their teams, and being able to rely on French cell technology fully aligns with our sovereignty approach,” said Julien Théodore, Design Authority Airborne at Alta Ares.

A First Commercial Order Opening New Opportunities

This first order comes at a time when a significant share of high-performance lithium-ion cells comes from suppliers located outside Europe. By equipping Alta Ares’ interceptor drone, Novacium is positioning itself at the centre of a strategic challenge involving technological sovereignty, performance and security of supply for European defence systems.

The transition from a test campaign to a commercial order for more than 100 units, with the prospect of an ongoing supply agreement, provides a concrete reference that could support the development of new commercial opportunities in the drone and defence sectors.

“We would like to warmly thank the Alta Ares teams for their cooperation, availability and excellent spirit of collaboration throughout this project. It is this relationship of trust that made this result possible, and we look forward to continuing it,” said Bernard Tourillon, President and CEO of HPQ Silicon Inc., which itself, IS President of Novacium.

Additional Information:

[1] NATO — Alta Ares won the competition with a system using artificial intelligence for the early detection and identification of threats. [Source: NATO – Innovation for the Front Line].

[2] NATO confirms that Alta Ares participated, alongside other companies, in a campaign during which integrated systems were evaluated against simulated and real targets at DGA test facilities. [Source: NATO – Ukraine Support: Counter-Glide Bomb Solutions Tested].

[3] According to Alta Ares, Pixel Lock has been developed and validated in real combat conditions within Ukrainian units since 2025. [Source: Alta Ares – MBDA x Alta Ares: an unprecedented partnership for a rapid and sovereign response to the drone threat].

[4] Detailed comparative technical data, including the weight of the AA NOVA pack and that of the reference battery, are not disclosed for confidentiality reasons.

About Novacium SAS

Novacium is a French deep-tech company based in Solaize, specializing in developing silicon-based anode materials for lithium-ion batteries using a proprietary process. The company also designs custom battery cells and packs for demanding applications, particularly in the defence, aerospace and portable energy sectors.

About Alta Ares

Alta Ares is a French defence technology company specializing in air defence and counter-drone solutions based on onboard artificial intelligence. Its technologies have been presented as part of NATO innovation initiatives and tested during campaigns involving NATO, the DGA and Ukrainian representatives. Alta Ares was also selected, alongside MBDA, as part of the ELISA innovation partnership launched by the DGA. The company develops a range of effectors and software solutions designed to counter the growing drone threat.

About HPQ Silicon

HPQ Silicon Inc. is a Quebec-based industrial issuer listed on the TSX Venture Exchange (TSX-V: HPQ), focused on innovation in advanced materials and developing critical processes.

HPQ holds a strategic 36.8% equity interest in Novacium, its research, development and commercialization partner. Together, HPQ and Novacium are developing next-generation silicon-based anode materials (Gen3 and Gen4) for batteries, pursuing commercialization of ENDURA+ lithium-ion cells, and developing innovative technologies for clean hydrogen production and energy recovery from waste materials. HPQ holds the exclusive rights to commercialize these technologies in North America.

Forward-Looking Statements

This press release contains forward-looking statements based on certain assumptions regarding technological performance, market demand, permitting, financing, supply chains and economic conditions. These statements involve significant risks, including delays, regulatory issues, competition, availability of financing and macroeconomic uncertainties. Actual results could differ materially from those anticipated. Detailed risk factors are presented in HPQ’s Annual Information Form available on SEDAR+. Forward-looking statements are provided solely to outline management’s future expectations and objectives. A more detailed cautionary note regarding forward-looking information related to the HPQ Endura+ batteries project is available for download [here]. Additional information regarding the Company is available on SEDAR+ (www.sedarplus.ca) and on the Company’s website at www.hpqsilicon.com/.

Neither the TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Contact Information

NOVACIUM SAS
Dr. Jed Kraiem, Ph.D., Chief Operating Officer
info@novacium.com

HPQ Silicon Inc.
Bernard J. Tourillon, BAA, MBA, President and CEO
info@hpqsilicon.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3a583994-0e4d-41f7-9779-ca94a56d2f4c

TORONTO, Sept. 17, 2026 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development, today announces Rodman & Renshaw has initiated coverage of Quantum BioPharma with a BUY rating and a US$8 price target. The lead analyst of this report is Michael G. King Jr., Director of Research, Senior Biotechnology Analyst at Rodman & Renshaw. This coverage is unpaid and Quantum BioPharma providing no consideration for this report.

Rodman & Renshaw published an initiation research report regarding Quantum BioPharma. The company did not pay Rodman & Renshaw any fees for this report.

A copy of this report can be found at: Quantum Published Initiation Report

About Quantum BioPharma Ltd.

Quantum is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (“Lucid”), Quantum is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. Quantum invented UNBUZZD™ and spun out its OTC version to a company, Unbuzzd Wellness Inc. (“Unbuzzd”) (formerly, Celly Nutrition Corp.), led by industry veterans. Quantum retains ownership of 19.48% (as of June 30, 2026) of Unbuzzd. The agreement with Unbuzzd also includes royalty payments of 7% of sales from unbuzzd™ until payments to Quantum total $250 million. Once $250 million is reached, the royalty drops to 3% in perpetuity. Quantum retains 100% of the rights to develop similar products or alternative formulations specifically for pharmaceutical and medical uses.

For more information visit www.quantumbiopharma.com.

About Rodman & Renshaw

Rodman & Renshaw (“Rodman”) is a full-service Investment Bank with a rich heritage spanning over 70 years. Rodman has deep rooted experience as a leading investment bank, fostering the long-term success of growth companies through Investment Banking, Equity Research, Corporate Access, and Strategic Advisory.

For more information visit www.rodm.com

Forward-Looking Information

This press release contains forward-looking statements within the meaning of applicable securities laws, including the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are generally identified by words such as “may,” “will,” “could,” “should,” “would,” “anticipate,” “expect,” “intend,” “plan,” “believe,” “estimate,” “potential,” “continue,” and similar expressions, although not all forward-looking statements contain these identifying words. These statements are based on the Company’s current expectations, estimates, assumptions and projections and are subject to known and unknown risks, uncertainties and other factors that could cause actual results, performance or achievements to differ materially from those expressed or implied by such statements.

Forward-looking statements in this press release should be considered in light of the risks and uncertainties described in the Company’s filings with applicable securities regulators, including its filings on SEDAR+ and with the U.S. Securities and Exchange Commission on EDGAR. Readers are cautioned not to place undue reliance on forward-looking statements. Except as required by applicable law, the Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Contacts:

Investor Relations
Robert Guzman, Investor Relations
Email: Rob@QuantumBioPharma.com
Telephone: (833) 304-0323
General Inquiries: info@QuantumBioPharma.com

CALGARY, Alberta, Sept. 17, 2026 (GLOBE NEWSWIRE) — Condor Energies Inc. (“Condor” or the “Company”) (TSX: CDR), a Canadian based, internationally focused energy transition company with active Central Asian operations is pleased to provide an operational update on its Uzbekistan project.

The Kumli-48 horizontal well (“K-48”) was recently drilled to a total depth of 3,233 meters and includes an 863-meter open-hole lateral section into a lower carbonate reservoir interval that was identified by the previously drilled K-42 vertical well. K-48 initially flowed at a peak rate of 19.5 MMscf/d (or 3,250 boe/d) but was rate restricted to manage the high gas stream velocities. K-48 was tested on a 1” choke for four hours at an average rate of 18.1 MMscf/d (or 3,017 boe/d) with a flowing tubing pressure of 1,005 psi. Formation water production was negligible and the preliminary condensate-gas ratio from the flow test is 7.6 barrels per MMscf. The well is currently being tied in and will begin producing to gas sales shortly.

The Kumli 50 horizontal well (“K-50”) which drilled the same lower carbonate reservoir has reached a total depth of 3,375 meters and is currently being completed prior to testing. The drilling rig from K-50 has commenced drilling the K-51 horizontal well which targets the same prolific lower carbonate reservoir as the K-48 and K-50 wells and the drilling rig from K-48 has moved to the adjacent Andakli field to begin drilling the A-22 horizontal well which targets a regionally extensive stratigraphic carbonate play.

Figure 1

Figure 1: Kumli NW field Pads and development wells

Don Streu, Condor’s President and CEO commented: “The very strong flow results from K-48 and its predecessors demonstrate the transformative impact horizontal wells can deliver and validates the significant value realized by successfully applying proven reservoir characterization and modern drilling technologies.

The Company has now drilled eight wells on the Kumli Northwest structure in 2026 that have added significant production volumes, while the drillable prospect inventory has grown to 58 and continues to expand our multi-year drilling program. Relocating one of the rigs to the Andakli field in the northern part of the concession becomes part of Condor’s next growth engine to further enhance long-term value in Uzbekistan. Andakli is a large area of established gas charge where the team has recently tested and flowed gas outside of existing mapped structural closure boundaries. Given that we have already proven the commerciality of horizontal developments at Kumli, this opens significant prospective drilling acreage at Andakli while the second rig continues to monetize the Kumli field”.

ABOUT CONDOR ENERGIES INC

Condor Energies Inc is a TSX-listed energy transition company that is uniquely positioned on the doorstep of European and Asian markets with three distinct first-mover energy security initiatives: increasing natural gas and condensate production from its existing fields in Uzbekistan; an ongoing project to construct and operate Central Asia’s first LNG ‘lower carbon fuel’ diesel substitution facility in Kazakhstan; and a separate initiative to develop and produce critical minerals from brines in Kazakhstan. Condor has already built a strong foundation for reserves, production and cashflow growth while also striving to minimize its environmental footprint.

The Company recognizes 100% of the production volumes, sales volumes, sales revenues, royalties and expenses related to the production enhancement contract project in Uzbekistan (“PEC Project”) and then allocates 49% of the comprehensive income (loss) attributable to the non-controlling interest holder. This is consistent with the accounting and disclosure in the Company’s financial statements. Accordingly, the production volumes disclosed in this news release related to the PEC Project are 100% of the amounts attributable to the PEC Project, of which 51% are attributable to the Company.

FORWARD-LOOKING STATEMENTS

Certain statements in this news release constitute forward-looking information under applicable securities legislation. Such statements are generally identifiable by the terminology used, such as “is”, “expect”, “plan”, “estimate”, “may”, “will”, “could”, “ongoing”, “predict”, “future”, “continue”, “upcoming”, “possible”, “continue”, “extend”, “advance”, “on track”, “underway”, “leading” or other similar wording. Forward-looking information in this news release includes, but is not limited to: the timing and ability to drill, complete, test, tie in and produce new wells; the timing and ability to restrict gas flows and manage high gas stream volumes; the timing and ability to target the same lower carbonate reservoir as K-48 and K-50; the timing and ability to target the regionally extensive stratigraphic carbonate play; the timing and ability of the horizontal wells to deliver transformative impact and significant value; the timing and ability to successfully apply proven reservoir characterization and modern drilling technologies; the timing and ability of the drilling inventory locations to be drilled and become producing wells; the timing and ability to expand the multi-year drilling program; the timing and ability for Andakli to become part of the next growth engine to enhance long-term value; the timing and ability to test and flow gas outside of existing mapped structural closure boundaries; the timing and ability to deliver on the Company’s broader initiatives to increase natural gas and condensate production in Uzbekistan, construct and operate an LNG facility in Kazakhstan, and to develop and produce critical minerals from brines in Kazakhstan.

By its very nature, such forward-looking information requires Condor to make assumptions that may not materialize or that may not be accurate including, but not limited to, the assumptions that: the Company will be able to fund its initiatives through a combination of cash on hand, increased cashflows, debt or equity financing, asset sales, or other financing arrangements; the financing available to the Company will be on terms acceptable to the Company, the Company will be able to manage liquidity and capital expenditures through budgeting and authorizations for expenditures; the Company will be able to manage health, safety, and operational risks through existing precautions and guidelines; the Company will be able to adapt to changing trade policies, tariffs, and restrictions; the Company will be able to obtain various approvals to conduct its planned exploration and development activities; the Company will be able to access natural gas pipelines as planned, the Company will be able to access sales markets as planned, the Company will have accurately estimated the anticipated capital expenditures and anticipated potential budgeting shortfalls; and the Company will be able to manage the impact of geopolitical instability and sanctions. Forward-looking information is subject to both known and unknown risks and uncertainties and other factors, which may cause actual results, levels of activity and achievements to differ materially from those expressed or implied by such information. Such risks and uncertainties include, but are not limited to: regulatory changes including changes to environmental regulations; the timing of regulatory and government approvals and the possibility that such approvals may be delayed or withheld; the risk that results of exploration and development drilling and related activities differ from what was initially anticipated; the risk that historical production and testing rates may not be indicative of future production rates, capabilities or ultimate recovery; the risk that the historical composition and quality of oil and gas does not accurately predict its future composition and quality; the risks associated with general economic, market and business conditions; risks relating to the uncertainty related to marketing and transportation; the risk of competitive action by other companies; risks associated with market fluctuations, particularly with respect to oil and natural gas prices; the effects of weather and climate conditions; fluctuation in interest rates and foreign currency exchange rates; the ability of suppliers to meet commitments; unanticipated actions by governmental authorities, including increases in taxes, tariffs, levies and fees; decisions or approvals of administrative tribunals and the possibility that government policies or laws may change or the possibility; risks associated with oil and gas operations, both domestic and international and other factors, many of which are beyond the control of Condor.

These risk factors are discussed in greater detail in filings made by Condor with Canadian securities regulatory authorities including the Company’s most recent Annual Information Form, which may be accessed through at www.sedarplus.ca.

Readers are cautioned that the foregoing list of important factors affecting forward-looking information is not exhaustive. The forward-looking information contained in this news release are made as of the date of this news release and, except as required by applicable law, Condor does not undertake any obligation to update publicly or to revise any of the included forward-looking information, whether as a result of new information, future events or otherwise. The forward-looking information contained in this news release is expressly qualified by this cautionary statement.

BARRELS OF OIL EQUIVALENT

References herein to barrels of oil equivalent (“boe”) are derived by converting gas to oil in the ratio of six thousand standard cubic feet (“Mcf”) of gas to one barrel of oil based on an energy conversion method primarily applicable at the burner tip and does not represent a value equivalency at the wellhead. Given the value ratio based on the current price of crude oil as compared to natural gas is significantly different from the energy equivalency of 6 Mcf to 1 barrel, utilizing a conversion ratio at 6 Mcf to 1 barrel may be misleading as an indication of value, particularly if used in isolation.

ABBREVIATIONS
   
The following is a summary of abbreviations used in this news release:
   
MMscf million standard cubic feet
MMscf/d million standard cubic feet per day
boe/d barrels of oil equivalent per day
“ inch
psi pounds per square inch
% percent
LNG Liquefied Natural Gas
TSX Toronto Stock Exchange
   

The TSX does not accept responsibility for the adequacy or accuracy of this news release.

For further information, please contact Don Streu, President and CEO or Sandy Quilty, Vice President of Finance and CFO at 403-201-9694.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c4e382d0-b794-422c-8550-d194980e5032

TORONTO, Sept. 17, 2026 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology solution provider specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, announces that it has been selected as a qualified supplier under the Government of Canada’s Defence Drone Initiative (DDI) Marketplace. The qualification establishes ZenaTech as part of the Government of Canada’s pre-qualified supplier pool, creating a pathway to compete for future defense and security drone requirements supporting the Canadian Armed Forces and Canadian Coast Guard.

“Being selected for Canada’s Defence Drone Initiative Marketplace represents an important milestone for our growing defense business,” said Shaun Passley, Ph.D., ZenaTech CEO. “We have been investing in autonomous drone technology, AI, manufacturing, and advanced capabilities designed for real-world defense and government applications, and we look forward to demonstrating how our ZenaDrone solutions can contribute to Canada’s objective of building a strong domestic drone and autonomous systems industry. Our goal is to continue advancing our technology and manufacturing capabilities so that ZenaDrone can become an important supplier of autonomous drone solutions to Canada and allied governments.”  

Launched by the Government of Canada in July 2026, the Defence Drone Initiative is designed to accelerate the development, testing, adaptation and production of uncrewed and autonomous systems while strengthening Canada’s domestic defense industrial capacity. Qualification under the DDI Marketplace does not constitute the award of a procurement contract, but it positions ZenaTech to apply and compete for applicable future requirements issued through the Marketplace.

ZenaDrone’s defense-focused portfolio is anchored by the ZenaDrone 1000, a multifunction autonomous drone platform built for surveillance, reconnaissance, logistics and specialized cargo missions currently at the testing stage. The IQ Series of drones range from an indoor inventory management and security drone to inspection, land surveys and mapping, and an underwater drone. The Company’s counter-UAS maritime interceptor drones and launch and refueling station, part of an integrated defense system, are currently in development. These platforms are being created to combine AI-driven autonomy, advanced sensors and modular payloads designed to meet the demanding requirements of defense and security operators and are being developed in parallel with ZenaTech’s ongoing manufacturing facility expansion across Arizona, Dubai and Taiwan.

About ZenaTech

ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) is a technology company that specializes in AI autonomy drone platforms to transform commercial, government, and defense sectors. Its subsidiaries include drone manufacturing through ZenaDrone, a global Drone as a Service (DaaS) business, and an enterprise SaaS division of software brands. The Company is executing an acquisition-led DaaS roll-up strategy to digitize and automate legacy service industries including land surveys and inspections, driving drone-based scalable and recurring revenue growth. With an operating footprint spanning North America, Europe, the Middle East, Asia, and Australia, ZenaTech is advancing AI drones for agriculture and logistics, as well as ISR, cargo, and counter-UAS applications for U.S. defense and NATO allies. The company is investing in next-generation technologies, including drone swarms, quantum computing, and advanced AI autonomy to capture long-term opportunities in key markets through its R&D initiatives.

About ZenaDrone

ZenaDrone, a subsidiary of ZenaTech, develops and manufactures AI-powered multifunction autonomous drone solutions integrating machine learning, predictive analytics, and advanced computing technologies, for government, defense, and industrial applications. This includes multifunctional drones for surveying, inspections, logistics, security, and defense applications. Its product portfolio includes the ZenaDrone 1000 for ISR defense and specialized cargo, the IQ Nano for indoor inventory management and security, the IQ Square for outdoor inspections and maintenance, the IQ Quad for land surveying, and the IQ Aqua for underwater applications. ZenaDrone operates three global manufacturing facilities in Arizona, Dubai, and Taiwan, and is advancing counter-UAS maritime interceptor drones and an integrated defense system.

Contacts for more information:

Company, Investors, and Media:
Linda Montgomery
ZenaTech
312-241-1415

Investors:
Michael Mason
CORE IR
investors@zenatech.com

Safe Harbor

This press release and related comments by management of ZenaTech, Inc. include “forward-looking statements” within the meaning of U.S. federal securities laws and applicable Canadian securities laws. These forward-looking statements are subject to the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. This forward-looking information relates to future events or future performance of ZenaTech and reflects management’s expectations and projections regarding ZenaTech’s growth, results of operations, performance, and business prospects and opportunities. Such forward-looking statements reflect management’s current beliefs and are based on information currently available to management. In some cases, forward-looking information can be identified by terminology such as “may”, “will”, “should”, “expect”, “plan”, “anticipate”, “aim”, “seek”, “is/are likely to”, “believe”, “estimate”, “predict”, “potential”, “continue” or the negative of these terms or other comparable terminology intended to identify forward-looking statements. Forward-looking information in this document includes, but is not limited to ZenaTech’s expectations regarding its revenue, expenses, production, operations, costs, cash flows, and future growth; expectations with respect to future production costs and capacity; ZenaTech’s ability to deliver products to the market as currently contemplated, including its drone products including ZenaDrone 1000, IQ Square, IQ Nano, IQ Quad, ZenaTech 2000, IQ Glider, IQ Sphere, IQ Aqua and Interceptor P-1; ZenaTech’s ability to develop products for markets as currently contemplated; ZenaTech’s anticipated cash needs and its needs for additional financing; ZenaTech’s intention to grow the business and its operations and execution risk; expectations with respect to future operations and costs; the volatility of stock prices and market conditions in the industries in which ZenaTech operates; political, economic, environmental, tax, security, and other risks associated with operating in emerging markets; regulatory risks; unfavorable publicity or consumer perception; difficulty in forecasting industry trends; the ability to hire key personnel; the competitive conditions of the industry and the competitive and business strategies of ZenaTech; ZenaTech’s expected business objectives for the next twelve months; ZenaTech’s ability to obtain additional funds through the sale of equity or debt commitments; investment capital and market share; the ability to complete any contemplated acquisitions; changes in the target markets; market uncertainty; ability to access additional capital, including through the listing of its securities in various jurisdictions; management of growth (plans and timing for expansion); patent infringement; litigation; applicable laws, regulations, and any amendments affecting the business of ZenaTech and other related risks and uncertainties disclosed under the heading “Risk Factors” in the Company’s Form F-1, Form 20-F and other filings filed with the United States Securities and Exchange Commission (the “SEC”) on EDGAR through the SEC’s website at www.sec.gov. The Company undertakes no obligation to update forward-looking information except as required by applicable law. Such forward-looking information represents management’s best judgment based on information currently available. No forward-looking statement can be guaranteed and actual future results may vary materially. Accordingly, readers are advised not to place undue reliance on forward-looking statements or information.

Facilities Expected to Fund the Majority of Turtle Creek’s Sub-$800 Million Estimated Project Cost

Company’s $2.4 Billion Contracted Forward Sales Position and Expected Operating Cash Flow Provide Credible Pathway to Fully Fund Turtle Creek

TERRE HAUTE, Ind., Sept. 17, 2026 (GLOBE NEWSWIRE) — Hallador Energy Company (Nasdaq: HNRG) (“Hallador” or the “Company”) today announced that on September 15, 2026, the Company closed a $600 million senior secured term loan facility (the “Term Loan Facility”) with a three-year term and, subject to lender approval, a two-year extension option. The Term Loan Facility consists of approximately $550 million funded at closing and an additional $50 million delayed draw term loan commitment available for up to 12 months. In connection with the Term Loan Facility, the Company also has the ability to establish a super-priority revolving credit facility of up to $75 million with a similar tenor, creating a financing package (collectively, the “Facilities”) of up to $675 million.

Hallador expects to use borrowings from the Facilities primarily to fund upcoming payment obligations under its turbine asset purchase agreement, transportation and refurbishment costs, pre-notice-to-proceed and other development costs, and construction of the Company’s proposed new and efficient 460-megawatt natural gas fired Turtle Creek Gas project (“Turtle Creek”), which has an expected total project cost of less than $800 million. Approximately $120 million of the proceeds from the Term Loan Facility will be used to repay the Company’s existing $45 million term loan and $75 million revolving credit facility. Proceeds will also be used for general corporate purposes.

The Company believes the Facilities represent the largest component of its overall financing plan for Turtle Creek and address the majority of Turtle Creek’s expected capital requirements. The Company is actively evaluating and expects to pursue additional financing sources to strengthen its capital structure. Together with the operating cash flow Hallador expects to generate between now and commercial operation of Turtle Creek, supported by the Company’s contracted forward sales position, management believes the Company has a credible pathway and sufficient time to fully fund the project consistent with its objective of little to no equity dilution.

“Closing this loan is the largest single step in financing Turtle Creek,” said Brent Bilsland, Chairman and Chief Executive Officer. “We chose this structure because it carries more debt than traditional bank project financing would typically allow. We are paying a higher rate for that capital, and we accept the trade. As Turtle Creek approaches and enters commercial operation, we expect to be able to refinance the loan on terms that reflect an operating plant.”

Bilsland continued, “Turtle Creek would continue Hallador’s transformation into a multi-fuel independent power producer and expand the scale of our power generation business. By leveraging existing infrastructure and critical generation equipment we have under contract, we believe we have positioned Turtle Creek to reach commercial operation on an accelerated timeline and at a capital cost well below comparable new generation projects. With demand for reliable, dispatchable power continuing to grow in MISO, we believe the combination of speed to market and capital efficiency makes Turtle Creek a compelling opportunity for Hallador and its shareholders. What the team remains focused on executing is straightforward but not assured: the turbines have to load, clear export, and be refurbished on schedule, and we have to contract the plant’s output at prices that justify the cost, as we have done at Merom.”

Kennedy Lewis Investment Management LLC provided the Term Loan Facility.

PEI Global Partners acted as the exclusive financial advisor to Hallador in connection with this transaction.

Turtle Creek Project Update

Development of Turtle Creek continues to progress. While certain development milestones have taken longer than initially anticipated, none has changed the Company’s view of the project’s economics or its targeted commercial operation date. Turbine shipment activities remain on schedule, and the Company expects to complete the purchase of the equipment in accordance with the terms of the previously filed turbine asset purchase agreement. The equipment is then expected to be transported to Siemens’ U.S. facilities for refurbishment in the coming months.

Hallador’s remaining development milestones continue to advance. The Company expects to execute the Generator Interconnection Agreement (“GIA”) in the coming weeks. Negotiations on the project’s engineering and construction agreement are in their final stages..

Hallador does not expect a long-term power purchase agreement to be a condition to its final investment decision (“FID”). As of June 30, 2026, the Company had approximately $2.4 billion of contracted forward sales under multi-year agreements with utilities and other counterparties. The Company believes this contracted position provides the foundation to proceed to FID on Turtle Creek. As a new natural gas-fired resource, Turtle Creek is expected to be attractive to counterparties seeking long-duration dispatchable supply, and discussions with prospective counterparties for Turtle Creek’s output are ongoing.

Turtle Creek, like the Company’s Merom Generating Station, is located in the MISO market. The Company believes current MISO market pricing for capacity and energy is supportive of new dispatchable generation, and its decision to advance Turtle Creek toward FID reflects that view.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Statements that are not strictly historical statements constitute forward-looking statements and may often, but not always, be identified by the use of such words as “expects,” “believes,” “intends,” “anticipates,” “plans,” “estimates,” “guidance,” “target,” “potential,” “possible,” or “probable” or statements that certain actions, events or results “may,” “will,” “should,” or “could” be taken, occur or be achieved. Forward-looking statements include, without limitation, those relating to the availability of the delayed draw term loan commitment, the exercise of the extension option, the establishment of the revolving credit facility, the expected use of proceeds from the Facilities, the timing and outcome of any final investment decision on Turtle Creek, the development, construction, financing and commercial operation of Turtle Creek, the Company’s evaluation and pursuit of additional financing sources, the timing of the Company’s remaining capital requirements, the timing, terms and availability of any additional financing and the Company’s discussions with financing partners, the Company’s ability to achieve its objective of little to no equity dilution, the Company’s contracted forward sales position and the performance of counterparties thereunder, the Company’s ability to contract Turtle Creek’s capacity and energy on acceptable terms and the timing of FID relative to any such contracts, the Company’s ability to refinance the Term Loan Facility following commercial operation and the terms of any such refinancing, the repayment of existing indebtedness, the timing of turbine shipment, completion of the equipment purchase and refurbishment, MISO market conditions and demand for Turtle Creek’s capacity and energy, the execution of a Generator Interconnection Agreement with MISO, engineering and construction agreements, and agreements for the sale of capacity and energy, expected total project costs and capital requirements, expected operating cash flow, and the Company’s objective of limiting equity dilution. Forward-looking statements are based on current expectations and assumptions and analyses made by Hallador and its management in light of experience and perception of historical trends, current conditions and expected future developments, as well as other factors appropriate under the circumstances that involve various risks and uncertainties that could cause actual results to differ materially from those reflected in the statements. These risks include, but are not limited to, those set forth in Hallador’s annual report on Form 10-K for the year ended December 31, 2025, and other Securities and Exchange Commission filings. Hallador undertakes no obligation to revise or update publicly any forward-looking statements except as required by law.

About Hallador Energy Company

Hallador Energy Company (Nasdaq: HNRG) is a vertically integrated Independent Power Producer (IPP) based in Terre Haute, Indiana. The Company has two core businesses: Hallador Power Company, LLC, which produces electricity and provides accredited capacity at its one-Gigawatt (GW) Merom Generating Station, and Sunrise Coal, LLC, which produces and supplies fuel to the Merom Generating Station and other companies. To learn more about Hallador, visit the Company’s website at http://www.halladorenergy.com.

Company Contact

Todd E. Telesz
Chief Financial Officer
TTelesz@halladorenergy.com

Investor Relations Contact

Sean Mansouri, CFA
Elevate IR
(720) 330-2829
HNRG@elevate-ir.com

Survey finds that 59% of homeowners are concerned that local outages will become more common; 75% worry that growing number of data centers could contribute to future outages

SAN FRANCISCO, Sept. 17, 2026 (GLOBE NEWSWIRE) — Nearly three in five (59%) Americans are concerned about power outages becoming more common where they live, according to a new survey of 2,000 American homeowners conducted by Talker Research on behalf of Sunrun (Nasdaq: RUN), America’s largest provider of home battery storage, solar, and home-to-grid power plants.

The survey results are being released to coincide with National Preparedness Month, reinforcing this year’s theme of “Americans Stand Ready.” Two-thirds of American homeowners reported already experiencing a power outage in 2026, and nearly three-quarters of those affected said they are worried they’ll experience another within the next year.

“Power outages are no longer something homeowners only think about when a major storm is approaching,” said Sunrun CEO Mary Powell. “Americans are concerned about the availability and reliability of their power supply and are seeking the peace of mind that comes from being prepared with home backup power for when the grid goes down.”

For homeowners who have already experienced an outage this year, their households experienced an average of three outages. And their most recent outage lasted an average of 5.5 hours, although some homeowners reported going without power for days.

Power Outage Reality Check

65% of homeowners surveyed believe power outages will occur the same as they do now or more frequently in the future, compared to just 16% who think they’ll become less frequent. Despite expecting an increased frequency of outages, many Americans are ready to admit just how not ready they are for when the lights go out.

Homeowners rated their “household preparedness” for a power outage at 6.6 out of 10 on average, and nearly half (47%) of homeowners said they have experienced a “power outage reality check” that made them realize they weren’t even close to being prepared.

Skepticism About Grid’s Ability To Meet Demand

Homeowners aren’t necessarily confident the power grid can keep pace with changing electricity demands. 75% are concerned that the growing number of data centers in the U.S. could play a role in future outages.

Adding to their fears about potential future outages, only a third (38%) are confident their local grid can reliably meet increased electricity demand from data centers.

When asked what poses the biggest threat to their area’s power reliability, homeowners overwhelmingly view severe storms as the primary threat. In fact, when combined with winter weather and extreme heat, weather-related events captured more than half of all respondents’ concerns.

48% of those who lost power at their home said they made a change to prepare for the next blackout. In terms of which improvement would make them feel most prepared for the next outage, 47% said a backup power source — the top answer by 18 points.

Power Outage Disruptions

The consequences of power outages go well beyond sitting in the dark. Among those who said they experienced an outage, the greatest disruptions included losing heating or cooling (57%), food spoilage (48%), and losing internet or cell service (44%).

Nearly one-third of homeowners (32%) have even sought shelter at the home of a family member, friend, or neighbor during an outage because that household still had electricity from the grid or a source of backup power.

The stakes were even higher for the 28% of homeowners who said someone in their household relies on electricity for a health-related need.

Among those households, electrically dependent needs included refrigerated prescription medications such as insulin (39%), CPAP machines (36%), oxygen equipment (30%), and medical monitoring devices such as glucose monitors (29%).

“A power outage can quickly become more than an inconvenience when it affects the essentials families rely on every day, from keeping food and medications refrigerated to maintaining a safe temperature at home,” Powell added. “Home battery storage paired with solar can provide greater energy resilience by helping keep critical parts of the home running when the grid goes down.”

Sunrun’s Solution For Families and the Grid

With the power grid aging, demand for electricity rising, and outages becoming more frequent, more and more Americans are seeking energy independence and protection from blackouts and rising energy rates. Serving more than 1.2 million customers nationwide, Sunrun leads the industry with home battery and solar energy systems without any upfront costs, enabling more families to affordably gain energy security.

Homeowners with a Sunrun battery-plus-solar system can comfortably power through extended grid outages without needing gasoline for a noisy generator or worrying about the limited capacity of portable storage devices. Sunrun’s whole-home battery storage capacity allows homeowners to run heating, air conditioning, and large appliances without interruption.

Even when the grid is operating normally, Sunrun’s home batteries empower homeowners to manage peak energy rates and achieve utility bill savings. By drawing daily on their own stored energy generated from their rooftop solar panels, homeowners can reduce the amount of costly energy they consume from the grid.

Sunrun’s unique solution doesn’t just benefit individual households. The battery systems also enable customers to support their local power grid through Sunrun’s distributed power plant programs. Customers are compensated for sharing energy with the grid during peak demand hours, helping control costs and prevent grid emergencies for all residents in their communities.

About Sunrun
Sunrun Inc. (Nasdaq: RUN) is America’s largest provider of home battery storage, solar, and home-to-grid power plants. As the pioneer of home energy systems offered through a no-upfront-cost subscription model, Sunrun empowers customers nationwide with greater energy control, security, and independence. Sunrun supports the grid by providing on-demand dispatchable power that helps prevent blackouts and lowers energy costs. Learn more at www.sunrun.com.

Media Contact
Wyatt Semanek
Sr. Director, Corporate Communications
press@sunrun.com

Investor & Analyst Contact
Patrick Jobin
SVP, Deputy CFO & Investor Relations Officer
investors@sunrun.com

Research methodology:
Talker Research conducted an online survey of 2,000 homeowners who have access to the internet from August 18 through 24, 2026; the survey was commissioned by Sunrun and administered and conducted by Talker Research. A link to the questionnaire can be found here.

To view the complete methodology as part of AAPOR’s Transparency Initiative, please visit the Talker Research Process and Methodology page.

Apollo Receives Minority Interest in Part of BMG’s Music Rights Portfolio; Equity Capital Enables BMG to Partially Repay Outstanding ABS Liabilities

NEW YORK, Sept. 17, 2026 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced that Apollo-managed funds and affiliates have provided a $1.25 billion equity capital solution to support the recently completed combination of BMG and Concord, bringing together two highly complementary businesses spanning music publishing, recorded music, theatrical rights and digital distribution. The combined company retains the BMG name and is headquartered in Nashville, Tennessee.

Under the terms of the transaction, Apollo acquired a noncontrolling interest in a subsidiary of BMG, which holds the legacy Concord ABS, backed by a catalog of over 1 million songs. Apollo’s equity investment enables BMG to repay certain outstanding ABS liabilities.

Apollo Partner Jamshid Ehsani said, “We are pleased to support the transformative combination of BMG and Concord through a tailored, non-dilutive equity investment that strengthens the combined company’s financial positioning as it enters this exciting next chapter. This transaction is indicative of Apollo’s growing role as a provider of high-grade capital solutions to leading corporations across an expanding range of industries and use cases, leveraging our scaled permanent capital base.”

BMG CEO Bob Valentine said, “The combination of BMG and Concord marks a defining moment in our company’s evolution. Apollo’s continued partnership and confidence in our strategy further strengthens our financial foundation and positions us to champion artists and songwriters, and to pursue global long-term growth opportunities. Together, we are building a stronger global music company with the scale, capabilities, and resources to capitalize on the opportunities ahead.”

Since 2022, Apollo has supported Concord’s issuance of over $4.5 billion of ABS debt through a long-term financing partnership. Over the past five years, Apollo has originated over $8 billion in music industry investments.

Deutsche Bank served as financial advisor and Latham & Watkins LLP served as legal counsel to Apollo. Goldman Sachs served as financial advisor to BMG, and DLA Piper and Davis Polk served as legal counsel to BMG on the transaction.

About Apollo
Apollo is a high-growth, global alternative asset manager. In our asset management business, we seek to provide our clients excess return at every point along the risk-reward spectrum from investment grade credit to private equity. For more than three decades, our investing expertise across our fully integrated platform has served the financial return needs of our clients and provided businesses with innovative capital solutions for growth. Through Athene, our retirement services business, we specialize in helping clients achieve financial security by providing a suite of retirement savings products and acting as a solutions provider to institutions. Our patient, creative, and knowledgeable approach to investing aligns our clients, businesses we invest in, our employees, and the communities we impact, to expand opportunity and achieve positive outcomes. As of June 30, 2026, Apollo had approximately $1.05 trillion of assets under management. To learn more, please visit www.apollo.com.

About BMG
Founded in 2008, BMG is committed to building the world’s most trusted, forward-looking music company. Following its combination with Concord in 2026, BMG brings together global scale, deep expertise, technology and partnership to unlock new opportunities for creators while protecting and growing the long-term value and cultural impact of their work.

BMG’s repertoire includes works by iconic global artists, songwriters, composers, and playwrights, including will.i.am, Phil Collins, Tina Turner, Lin-Manuel Miranda, Jason Aldean, Jelly Roll, Evanescence, Kylie Minogue, Billie Holiday, Rodgers & Hammerstein, Creedence Clearwater Revival, Tennessee Williams, OneRepublic, Daddy Yankee, and Leonard Bernstein.

Headquartered in Nashville with 18 offices globally, BMG is privately held and part of Bertelsmann, the international media, services and education company, with a minority stake held by affiliates of Great Mountain Partners.

Contacts

For Apollo:
Noah Gunn
Global Head of Investor Relations
Apollo Global Management, Inc.
(212) 822-0540
IR@apollo.com

Joanna Rose
Global Head of Corporate Communications
Apollo Global Management, Inc.
(212) 822-0491
Communications@apollo.com

For BMG:
Kristal McKanders Dube
EVP, Corporate Communications
BMG
kristal.mckanders@bmg.com

SINGAPORE, Sept. 17, 2026 (GLOBE NEWSWIRE) — GCL Global Holdings Ltd (Nasdaq: GCL) (“GCL” or the “Company”), a leading provider of games and entertainment, today announced that the listing of its ordinary shares will be transferred to The Nasdaq Capital Market at the opening of business on September 18, 2026. The Company’s ordinary shares will continue to trade under the ticker symbol “GCL,” and its warrants will continue to trade on The Nasdaq Capital Market under the ticker symbol “GCLWW.”

The transfer follows a deficiency notice dated March 17, 2026 the Company received regarding the minimum bid price requirement under Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Rule”). On September 16, 2026, the Company received written notification from Nasdaq advising the Company that it had been granted an additional 180 calendar days, or until March 15, 2027, to comply with the Minimum Bid Price Rule in connection with its application to transfer its listing to the Nasdaq Capital Market.

The transfer has no effect on the Company’s day-to-day business operations, financial condition, or reporting obligations under U.S. securities laws. The Company’s ordinary shares and warrants will continue to trade on Nasdaq without interruption.

About GCL Global Holdings

GCL Global Holdings Ltd. (“GCL”) is a holding company incorporated in the Cayman Islands (GCL together with its subsidiaries, the “GCL Group”). Through its operating subsidiaries, GCL Group unites people through its ecosystem of content and hardware in games and entertainment, enabling creators to deliver engaging experiences to gaming communities worldwide with a strategic focus on the rapidly expanding Asian gaming market.

Drawing on a deep understanding of gaming trends and market dynamics, GCL Group leverages its diverse portfolio of digital and physical content as well as multimedia peripherals to bridge cultures and reach a global audience by introducing Asian-developed IP across consoles and PCs. Learn more at https://www.gclglobalholdings.com/

Forward-Looking Statements

This press release contains forward-looking statements. All statements other than statements of historical fact are forward-looking statements, which are often indicated by terms such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “estimate,” “believe,” “predict,” “potential” or “continue,” among others, statements regarding our compliance with the Minimum Bid Price Rule and listing or trading of our ordinary shares. Forward-looking statements appear in a number of places throughout this press release and may include statements regarding our intentions, beliefs, projections, outlook, analyses, current expectations and the risks, uncertainties and other factors described under the headings, “Risk factors” and “Cautionary statement regarding forward looking statements,” in our periodic filings with the U.S. Securities and Exchange Commission. These statements speak only as of the date of this press release and involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Given these risks, uncertainties and other factors, you should not place undue reliance on these forward-looking statements, and we assume no obligation to update these forward-looking statements, even if new information becomes available in the future, except as required by law.

GCL Investor Relations:

Crocker Coulson
crocker.coulson@aumadvisors.com
(646) 652-7185

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.